SCHEMBL13086504

SCHEMBL13086504

CCOC(=O)CCCN(CCCS(=O)(=O)O)c1ccc(C)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.43
ALOX5 P09917 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 5/20 0.39
POLB P06746 1/20 0.39
RAB9A P51151 1/20 0.39
PPARG P37231 1/20 0.37
CYP4F2 P78329 1/20 0.36
CYP4A11 Q02928 1/20 0.36
CYP1A2 P05177 2/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
CNR2 P34972 1/20 0.36
ABL1 P00519 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2761731 0.90 SMN1; SMN2 (0.52) SMN1; SMN2ALOX5L3MBTL1ALDH1A1PPARG
SCHEMBL14947362 0.89 SMN1; SMN2 (0.51) SMN1; SMN2ALOX5L3MBTL1ALDH1A1POLB
SCHEMBL13086215 0.85 CNR2 (0.41) L3MBTL1ALDH1A1RAB9ACYP3A4CYP2C9
SCHEMBL13086171 0.84 LMNA (0.43) SMN1; SMN2L3MBTL1ALDH1A1RAB9ALMNA
SCHEMBL14619944 0.83 ALDH1A1 (0.42) SMN1; SMN2ALOX5ALDH1A1CYP4F2CYP4A11
SCHEMBL2762099 0.83 SMN1; SMN2 (0.45) SMN1; SMN2ALOX5ALDH1A1CYP4F2CYP4A11
SCHEMBL13084296 0.82 ALOX5 (0.34) SMN1; SMN2ALOX5L3MBTL1ALDH1A1PPARG
SCHEMBL15457594 0.81 ALOX5 (0.34) SMN1; SMN2ALOX5L3MBTL1ALDH1A1PPARG
SCHEMBL6302951 0.81 CNR2 (0.47) L3MBTL1ALDH1A1CYP2C9CYP2C19CNR2
SCHEMBL8911435 0.80 SMN1; SMN2 (0.54) SMN1; SMN2ALOX5ALDH1A1POLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8642014-B2 Luminescent compounds SETA BIOMEDICALS, LLC (US) 2014-02-04 US disclosed
US-20100266507-A1 LUMINESCENT COMPOUNDS SETA BIOMEDICALS, LLC 2010-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100266507-A1 LUMINESCENT COMPOUNDS SQLE, COASY, ZKSCAN2 SMN1; SMN2 4042/4885ALOX5 2467/4885L3MBTL1 398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.